協和キリンの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2017/12/25 | 2,160 | 2,164 | 2,147 | 2,159 | +12 | +0.6% | 277,700 |
| 2017/12/22 | 2,120 | 2,149 | 2,118 | 2,147 | +6 | +0.3% | 755,100 |
| 2017/12/21 | 2,147 | 2,149 | 2,122 | 2,141 | -7 | -0.3% | 736,500 |
| 2017/12/20 | 2,150 | 2,160 | 2,142 | 2,148 | -11 | -0.5% | 567,500 |
| 2017/12/19 | 2,190 | 2,190 | 2,155 | 2,159 | -30 | -1.4% | 898,700 |
| 2017/12/18 | 2,185 | 2,199 | 2,176 | 2,189 | +30 | +1.4% | 852,500 |
| 2017/12/15 | 2,160 | 2,177 | 2,145 | 2,159 | -5 | -0.2% | 1,163,500 |
| 2017/12/14 | 2,173 | 2,178 | 2,152 | 2,164 | +41 | +1.9% | 1,162,300 |
| 2017/12/13 | 2,121 | 2,136 | 2,114 | 2,123 | +13 | +0.6% | 1,029,700 |
| 2017/12/12 | 2,118 | 2,128 | 2,100 | 2,110 | -19 | -0.9% | 811,000 |
| 2017/12/11 | 2,091 | 2,129 | 2,089 | 2,129 | +53 | +2.6% | 905,200 |
| 2017/12/08 | 2,051 | 2,077 | 2,041 | 2,076 | +25 | +1.2% | 1,712,100 |
| 2017/12/07 | 2,013 | 2,059 | 2,012 | 2,051 | +48 | +2.4% | 1,223,500 |
| 2017/12/06 | 2,080 | 2,080 | 2,000 | 2,003 | -75 | -3.6% | 1,714,300 |
| 2017/12/05 | 2,056 | 2,090 | 2,052 | 2,078 | +3 | +0.1% | 862,300 |
| 2017/12/04 | 2,122 | 2,123 | 2,068 | 2,075 | -48 | -2.3% | 1,244,300 |
| 2017/12/01 | 2,150 | 2,156 | 2,103 | 2,123 | -6 | -0.3% | 1,159,800 |
| 2017/11/30 | 2,105 | 2,132 | 2,093 | 2,129 | +36 | +1.7% | 1,382,300 |
| 2017/11/29 | 2,095 | 2,104 | 2,076 | 2,093 | +7 | +0.3% | 1,008,900 |
| 2017/11/28 | 2,044 | 2,088 | 2,042 | 2,086 | +42 | +2.1% | 1,106,700 |
| 2017/11/27 | 2,057 | 2,073 | 2,036 | 2,044 | -24 | -1.2% | 1,088,500 |
| 2017/11/24 | 2,055 | 2,075 | 2,038 | 2,068 | -12 | -0.6% | 1,117,300 |
| 2017/11/22 | 2,125 | 2,138 | 2,076 | 2,080 | -30 | -1.4% | 1,287,800 |
| 2017/11/21 | 2,110 | 2,123 | 2,101 | 2,110 | -10 | -0.5% | 1,193,100 |
| 2017/11/20 | 2,149 | 2,156 | 2,114 | 2,120 | -44 | -2% | 1,039,600 |
| 2017/11/17 | 2,200 | 2,227 | 2,152 | 2,164 | -9 | -0.4% | 1,817,700 |
| 2017/11/16 | 2,074 | 2,178 | 2,074 | 2,173 | +109 | +5.3% | 1,650,800 |
| 2017/11/15 | 2,084 | 2,095 | 2,063 | 2,064 | -30 | -1.4% | 1,260,500 |
| 2017/11/14 | 2,089 | 2,119 | 2,079 | 2,094 | +5 | +0.2% | 1,001,800 |
| 2017/11/13 | 2,090 | 2,107 | 2,076 | 2,089 | -14 | -0.7% | 804,900 |
| 2017/11/10 | 2,096 | 2,114 | 2,070 | 2,103 | -13 | -0.6% | 1,486,200 |
| 2017/11/09 | 2,152 | 2,165 | 2,090 | 2,116 | -36 | -1.7% | 1,729,600 |
| 2017/11/08 | 2,167 | 2,171 | 2,131 | 2,152 | -42 | -1.9% | 1,416,100 |
| 2017/11/07 | 2,146 | 2,197 | 2,132 | 2,194 | +50 | +2.3% | 1,232,800 |
| 2017/11/06 | 2,172 | 2,181 | 2,129 | 2,144 | -11 | -0.5% | 845,200 |
| 2017/11/02 | 2,130 | 2,157 | 2,118 | 2,155 | +49 | +2.3% | 1,587,200 |
| 2017/11/01 | 2,107 | 2,112 | 2,082 | 2,106 | +18 | +0.9% | 1,328,100 |
| 2017/10/31 | 2,095 | 2,096 | 2,060 | 2,088 | -18 | -0.9% | 1,569,900 |
| 2017/10/30 | 2,108 | 2,112 | 2,079 | 2,106 | +13 | +0.6% | 2,404,700 |
| 2017/10/27 | 1,994 | 2,100 | 1,991 | 2,093 | +121 | +6.1% | 2,378,000 |
| 2017/10/26 | 1,984 | 1,997 | 1,960 | 1,972 | -24 | -1.2% | 1,229,500 |
| 2017/10/25 | 2,042 | 2,042 | 1,989 | 1,996 | -44 | -2.2% | 1,025,700 |
| 2017/10/24 | 2,030 | 2,044 | 2,023 | 2,040 | ±0 | ±0% | 655,200 |
| 2017/10/23 | 2,045 | 2,050 | 2,027 | 2,040 | +18 | +0.9% | 962,800 |
| 2017/10/20 | 2,020 | 2,039 | 2,009 | 2,022 | +3 | +0.1% | 954,000 |
| 2017/10/19 | 2,000 | 2,028 | 2,000 | 2,019 | +25 | +1.3% | 866,800 |
| 2017/10/18 | 2,000 | 2,001 | 1,985 | 1,994 | -4 | -0.2% | 1,019,100 |
| 2017/10/17 | 2,000 | 2,002 | 1,983 | 1,998 | +7 | +0.4% | 839,000 |
| 2017/10/16 | 1,973 | 1,996 | 1,967 | 1,991 | +10 | +0.5% | 791,600 |
| 2017/10/13 | 1,950 | 1,984 | 1,950 | 1,981 | +15 | +0.8% | 1,541,400 |
1801～
1850
件表示中 / 3699件
類似銘柄と比較する
現在ご覧いただいている「協和キリン」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 協和キリン | 217,200円 | -3.5% | -11.3% | 2.76% | 19.95倍 | 1.34倍 |
|
キリン傘下。医薬品、バイオが主力。独自の抗体高活性化技術に強み。富士フイルムと提携 |
| アステラス薬 | 134,100円 | +0.9% | +380.2% | 5.82% | 18.47倍 | 1.59倍 |
|
医薬品国内２位。開発技術起点の研究開発体制。前立腺がん薬が柱。遺伝子・細胞治療技術育成 |
| 塩野義 | 218,800円 | +20.9% | +10.6% | 3.02% | 10.34倍 | 1.37倍 |
|
抗ＨＩＶ薬が大型製品に。感染症、疼痛・中枢神経領域に強み。米国に積極展開。欧州、アジア開拓 |
| エーザイ | 366,700円 | +1.7% | -2.9% | 4.36% | 24.06倍 | 1.27倍 |
|
神経系、がん領域に強み。認知症薬は米バイオジェンと、抗がん薬では米メルクと国際協業推進 |
| 小野薬 | 149,200円 | +0.6% | +43.3% | 5.36% | 10.46倍 | 0.89倍 |
|
医療用医薬品専業の中堅。自社開発品多い。先駆的がん免疫阻害剤「オプジーボ」が成長牽引 |
市場注目の銘柄
チャート関連のコラム
